drugset / Trial / NCT00114517

ELITE: Early Versus Late Intervention Trial With Estradiol

NCT00114517

RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to examine the effects of oral 17B-estradiol (estrogen) on the progression of early (subclinical) atherosclerosis and cognitive decline in healthy postmenopausal women.

Timeline

Start
2004-07
Primary completion
2013-02-12
Completion
2013-03-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Estradiol Other / unclassified 1 mg Oral

Indications